Assignee
ONCORUS INC
US·5 granted patents·9 pending applications·11 citations·filing 2017–2022
Top patents by PatentIndex Score
14 records- 0190US10604574B2Oncolytic viral delivery of therapeutic polypeptidesONCORUS INC·Filed 2018·Granted Mar 31, 2020·4 cites·6 claims
- 0285US10391132B2Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2018·Granted Aug 27, 2019·3 cites·25 claims
- 0383US11452750B2Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2019·Granted Sep 27, 2022·2 cites·31 claims
- 0482US11078280B2Oncolytic viral delivery of therapeutic polypeptidesONCORUS INC·Filed 2020·Granted Aug 3, 2021·1 cites·13 claims
- 0574US2023115116A1Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2022·Application pending·0 cites
- 0672US11612625B2Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2018·Granted Mar 28, 2023·1 cites·26 claims
- 0771US2024173267A1Compounds, compositions, and methods of using thereofONCORUS INC·Filed 2022·Application pending·0 cites
- 0853US2018057594A1Pseudotyped oncolytic viral delivery of therapeutic polypeptidesONCORUS INC·Filed 2017·Application pending·0 cites
- 0951US2022380735A1Dual viruses and dual oncolytic viruses and methods of treatmentONCORUS INC·Filed 2020·Application pending·0 cites
- 1050US2022117902A1Encapsulated rna polynucleotides and methods of useONCORUS INC·Filed 2020·Application pending·0 cites
- 1149US2023416308A1Encapsulated rna replicons and methods of useONCORUS INC·Filed 2021·Application pending·0 cites
- 1248US2021403950A1Encapsulated polynucleotides and methods of useONCORUS INC·Filed 2019·Application pending·0 cites
- 1348US2023227577A1Anti-dll3 antibodies and methods of useONCORUS INC·Filed 2021·Application pending·0 cites
- 1442US2020224220A1Encapsulated polynucleotides and methods of useONCORUS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCORUS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →